Combined Phacoemulsification and Diode Laser Therapy in Chronic Angle Closure Glaucoma

Not Applicable

Active, not recruiting

• Conditions: Angle Closure Glaucoma
• Interventions: Procedure: phaco+MP-TSCPC; Procedure: phaco+endocyclophotocoagulation; Procedure: phaco+TSCPC; Procedure: phaco GSL

• Registration Number: NCT05576493
• Lead Sponsor: Cairo University

Brief Summary

comparing different types of cuclophotocoagulation with cataract extraction to cataract extraction and goniocynechiolysis in cases of chronic angle closure glaucoma

Detailed Description

Evaluation of the safety of MP-TSCPC , CW-TSCPC and endoscopic cyclophotocoagulation when combined with phacoemulsification in cases with CACG Comparing the efficacy of the combined procedures in control of the IOP and the success rate versus lens extraction combined with synechiolysis

Study Timeline

• Study Start: 2022-08-11
• Study First Submitted: 2022-10-08
• Study First Submitted QC: 2022-10-08
• Study First Posted: 2022-10-12
• Status Verified: 2023-08
• Last Update Submitted: 2023-08-29
• Last Update Posted: 2023-08-30
• Primary Completion: 2023-10-01
• Study Completion: 2023-12-01

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 88

Inclusion Criteria

• Patients between 20 to 70 years

chronic angle closure glaucoma

Exclusion Criteria

• Patients in acute attack of angle closure.
• Patients with previous filtering surgery or cycloablative procedure

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
A:phaco+MP-TSCPC	phaco+MP-TSCPC	22 patients with primary angle closure glaucoma will undergo phacoemulsification and micropulse cyclophotocoagulation
C:phaco+endocyclophotocoagulation	phaco+endocyclophotocoagulation	22 patients with primary angle closure glaucoma will undergo phaco and endocyclophotocoagulation after cataract removal
B:phaco+TSCPC	phaco+TSCPC	22 patients with primary angle closure glaucoma will undergo phaco and transscleral cyclophotocoagulation
D:phaco GSL	phaco GSL	22 patients with primary angle closure glaucoma will undergo phaco and goniosynechiolysis

Primary Outcome Measures

Name	Time	Method
the percentage of intraocular pressure change	6 Months	measuring the intraocular pressure after 1M, 3M and 6M

Secondary Outcome Measures

Name	Time	Method
percent change of antiglaucoma medications	6 Months	the number of medication before and after the procedure

Trial Locations

Locations (1)

Kasr Alainy; 🇪🇬 Cairo, Egypt